Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome–Coronavirus 2 Pandemic

Overview of attention for article published in Hepatology, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 75,461 followers.

RT @AASLDtweets: From @HEP_Journal: "Maintaining Patient Safety and Data Integrity of #NASH Clinical Trials During the SARS‐CoV‐2 Pandemic"…

RT @AASLDtweets: From @HEP_Journal: "Maintaining Patient Safety and Data Integrity of #NASH Clinical Trials During the SARS‐CoV‐2 Pandemic"…

RT @AlkhouriNaim: Our guide on how to optimize NASH clinical trails during COVID @DrLoomba @Pinnacle_TX @anitakohli @LiverArizona Maintain…

Honored to lead this effort to help research sites manage NASH trials during the COVID pandemic. @AlkhouriNaim @liverUSA @LiverForum @EASLnews @DCPatient

RT @AlkhouriNaim: Our guide on how to optimize NASH clinical trails during COVID @DrLoomba @Pinnacle_TX @anitakohli @LiverArizona Maintain…

Our guide on how to optimize NASH clinical trails during COVID @DrLoomba @Pinnacle_TX @anitakohli @LiverArizona Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic - PubMed https://t.co/ZPE7S1oFC2

Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic https://t.co/XyBi2auQmT